ERBB2 and neoplasm: The WHO Classification of Tumors: Breast Tumors, 5th Edition has also endorsed histopathological TIL quantification in TNBC and HER2-positive BCs, expressed as a mean percentage of lymphoplasmacytic infiltration of the tumor stroma53.